vs

Side-by-side financial comparison of CareTrust REIT, Inc. (CTRE) and Xometry, Inc. (XMTR). Click either name above to swap in a different company.

Xometry, Inc. is the larger business by last-quarter revenue ($192.4M vs $134.9M, roughly 1.4× CareTrust REIT, Inc.). CareTrust REIT, Inc. runs the higher net margin — 82.5% vs -4.5%, a 87.0% gap on every dollar of revenue. On growth, CareTrust REIT, Inc. posted the faster year-over-year revenue change (55.1% vs 29.5%). Over the past eight quarters, CareTrust REIT, Inc.'s revenue compounded faster (46.2% CAGR vs 25.2%).

Target Healthcare REIT is a British property investment company which invests in healthcare properties and holds a large portfolio of care homes. It is structured as a real estate investment trust (REIT) and is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.

Xometry is an online marketplace for sourcing on-demand manufactured parts for prototyping and large-scale production.

CTRE vs XMTR — Head-to-Head

Bigger by revenue
XMTR
XMTR
1.4× larger
XMTR
$192.4M
$134.9M
CTRE
Growing faster (revenue YoY)
CTRE
CTRE
+25.6% gap
CTRE
55.1%
29.5%
XMTR
Higher net margin
CTRE
CTRE
87.0% more per $
CTRE
82.5%
-4.5%
XMTR
Faster 2-yr revenue CAGR
CTRE
CTRE
Annualised
CTRE
46.2%
25.2%
XMTR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CTRE
CTRE
XMTR
XMTR
Revenue
$134.9M
$192.4M
Net Profit
$111.3M
$-8.6M
Gross Margin
39.1%
Operating Margin
-4.6%
Net Margin
82.5%
-4.5%
Revenue YoY
55.1%
29.5%
Net Profit YoY
113.5%
12.7%
EPS (diluted)
$0.52

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTRE
CTRE
XMTR
XMTR
Q4 25
$134.9M
$192.4M
Q3 25
$132.4M
$180.7M
Q2 25
$112.5M
$162.5M
Q1 25
$96.6M
$151.0M
Q4 24
$86.9M
$148.5M
Q3 24
$77.4M
$141.7M
Q2 24
$68.9M
$132.6M
Q1 24
$63.1M
$122.7M
Net Profit
CTRE
CTRE
XMTR
XMTR
Q4 25
$111.3M
$-8.6M
Q3 25
$74.9M
$-11.6M
Q2 25
$68.5M
$-26.4M
Q1 25
$65.8M
$-15.1M
Q4 24
$52.1M
$-9.9M
Q3 24
$33.4M
$-10.2M
Q2 24
$10.8M
$-13.7M
Q1 24
$28.7M
$-16.6M
Gross Margin
CTRE
CTRE
XMTR
XMTR
Q4 25
39.1%
Q3 25
39.9%
Q2 25
40.1%
Q1 25
37.3%
Q4 24
39.7%
Q3 24
39.4%
Q2 24
39.9%
Q1 24
39.0%
Operating Margin
CTRE
CTRE
XMTR
XMTR
Q4 25
-4.6%
Q3 25
58.1%
-6.1%
Q2 25
61.3%
-6.3%
Q1 25
-10.2%
Q4 24
-7.8%
Q3 24
43.0%
-8.1%
Q2 24
15.1%
-11.5%
Q1 24
-14.6%
Net Margin
CTRE
CTRE
XMTR
XMTR
Q4 25
82.5%
-4.5%
Q3 25
56.6%
-6.4%
Q2 25
60.9%
-16.3%
Q1 25
68.1%
-10.0%
Q4 24
60.0%
-6.7%
Q3 24
43.2%
-7.2%
Q2 24
15.6%
-10.3%
Q1 24
45.6%
-13.5%
EPS (diluted)
CTRE
CTRE
XMTR
XMTR
Q4 25
$0.52
Q3 25
$0.35
Q2 25
$0.35
Q1 25
$0.35
Q4 24
$0.30
Q3 24
$0.21
Q2 24
$0.07
Q1 24
$0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTRE
CTRE
XMTR
XMTR
Cash + ST InvestmentsLiquidity on hand
$198.0M
$219.1M
Total DebtLower is stronger
$894.2M
Stockholders' EquityBook value
$4.0B
$275.6M
Total Assets
$5.1B
$703.7M
Debt / EquityLower = less leverage
0.22×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTRE
CTRE
XMTR
XMTR
Q4 25
$198.0M
$219.1M
Q3 25
$712.5M
$224.5M
Q2 25
$306.1M
$225.8M
Q1 25
$26.5M
$231.4M
Q4 24
$213.8M
$239.8M
Q3 24
$377.1M
$234.0M
Q2 24
$495.1M
$240.9M
Q1 24
$451.2M
$253.8M
Total Debt
CTRE
CTRE
XMTR
XMTR
Q4 25
$894.2M
Q3 25
$893.8M
Q2 25
$1.2B
Q1 25
$822.1M
Q4 24
$396.9M
Q3 24
$396.7M
Q2 24
$671.1M
Q1 24
$595.9M
Stockholders' Equity
CTRE
CTRE
XMTR
XMTR
Q4 25
$4.0B
$275.6M
Q3 25
$4.0B
$272.0M
Q2 25
$3.3B
$270.4M
Q1 25
$2.9B
$309.9M
Q4 24
$2.9B
$314.5M
Q3 24
$2.4B
$315.2M
Q2 24
$1.9B
$315.8M
Q1 24
$1.7B
$320.4M
Total Assets
CTRE
CTRE
XMTR
XMTR
Q4 25
$5.1B
$703.7M
Q3 25
$5.1B
$698.9M
Q2 25
$4.7B
$687.0M
Q1 25
$3.9B
$690.1M
Q4 24
$3.4B
$680.1M
Q3 24
$2.9B
$678.2M
Q2 24
$2.7B
$678.6M
Q1 24
$2.3B
$692.5M
Debt / Equity
CTRE
CTRE
XMTR
XMTR
Q4 25
0.22×
Q3 25
0.22×
Q2 25
0.35×
Q1 25
0.28×
Q4 24
0.14×
Q3 24
0.16×
Q2 24
0.35×
Q1 24
0.36×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTRE
CTRE
XMTR
XMTR
Operating Cash FlowLast quarter
$394.0M
$4.4M
Free Cash FlowOCF − Capex
$-5.9M
FCF MarginFCF / Revenue
-3.0%
Capex IntensityCapex / Revenue
5.3%
Cash ConversionOCF / Net Profit
3.54×
TTM Free Cash FlowTrailing 4 quarters
$-24.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTRE
CTRE
XMTR
XMTR
Q4 25
$394.0M
$4.4M
Q3 25
$100.9M
$5.8M
Q2 25
$100.8M
$-427.0K
Q1 25
$71.4M
$-3.7M
Q4 24
$244.3M
$9.1M
Q3 24
$67.2M
$-3.6M
Q2 24
$53.0M
$-9.1M
Q1 24
$48.8M
$-11.7M
Free Cash Flow
CTRE
CTRE
XMTR
XMTR
Q4 25
$-5.9M
Q3 25
$-1.7M
Q2 25
$-7.4M
Q1 25
$-9.2M
Q4 24
$4.5M
Q3 24
$-8.4M
Q2 24
$-13.5M
Q1 24
$-16.1M
FCF Margin
CTRE
CTRE
XMTR
XMTR
Q4 25
-3.0%
Q3 25
-0.9%
Q2 25
-4.5%
Q1 25
-6.1%
Q4 24
3.1%
Q3 24
-6.0%
Q2 24
-10.2%
Q1 24
-13.1%
Capex Intensity
CTRE
CTRE
XMTR
XMTR
Q4 25
5.3%
Q3 25
4.1%
Q2 25
4.3%
Q1 25
3.6%
Q4 24
3.1%
Q3 24
3.4%
Q2 24
3.3%
Q1 24
3.5%
Cash Conversion
CTRE
CTRE
XMTR
XMTR
Q4 25
3.54×
Q3 25
1.35×
Q2 25
1.47×
Q1 25
1.08×
Q4 24
4.68×
Q3 24
2.01×
Q2 24
4.92×
Q1 24
1.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTRE
CTRE

Segment breakdown not available.

XMTR
XMTR

US$159.1M83%
Non Us$33.3M17%

Related Comparisons